But recently, GLP-1s have gained mainstream attention and adoption due to their applications for weight lossoriginally highlighted as a side effect. Those findings led to widespread media coverage and celebrity endorsements, helping fuel a rapid increase in interest and prescribing of GLP-1 medications
doi: 10.1155/2016/8917578 36 ShinSJChungSKimSJLeeEMYooYHKimJWet al
Pancreatic Cancer Risk GLP-1RA Drugs: Approved Uses, Benefits, and Common Side Effects The EU Food and Drug Administration has approved several GLP-1RA medications, such as exenatide, liraglutide, albiglutide, dulaglutide, lixisenatide, semaglutide, and tripeptide, offering a range of options for patients seeking treatment
No one considers a cholesterol of 300 a moral failing, but a BMI of 35 makes someone undisciplined. That type of thinking fails to recognize the neurobiology of weight management